Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus onHematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 7, 2013, Pages 1006-1012

  Kharfan Dabaja, Mohamed A ^a,b   Lazarus, Hillard M ^c   Nishihori, Taiga ^a,b   Mahfouz, Rami A ^d   Hamadani, Mehdi ^e  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Autologous transplantation; Blastic plasmacytoid dendritic cell neoplasm

Indexed keywords

CD123 ANTIGEN; CD2 ASSOCIATED PROTEIN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGRAFT; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; CANCER CELL; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CHROMOSOME ABERRATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PROGNOSIS; PROTEIN EXPRESSION; RARE DISEASE; RASH; REVIEW; SURVIVAL TIME; TREATMENT RESPONSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; CYTOSKELETAL PROTEINS; DENDRITIC CELLS; EXANTHEMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC FACTORS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879409907     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.01.027     Document Type: Review

References (43)

1. Chaperot L., Bendriss N., Manches O., et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001, 97:3210-3217.
2. Feuillard J., Jacob M.C., Valensi F., et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002, 99:1556-1563.
3. Facchetti F., Jones D., Petrella T. Blastic plasmacytoid dendritic cell neoplasm. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer, Lyon, France. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
4. Petrella T., Bagot M., Willemze R., et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005, 123:662-675.
5. Falcão R.P., Garcia A.B., Marques M.G., et al. Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity. Leuk Res 2002, 26:803-807.
6. Kojima H., Mukai H.Y., Shinagawa A., et al. Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas. Int J Hematol 2000, 72:477-483.
7. Bueno C., Almeida J., Lucio P., et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica 2004, 89:58-69.
8. Oshimi K., Kawa K., Nakamura S., et al. NK-cell neoplasms in Japan. Hematology 2005, 10:237-245.
9. Garnache-Ottou F., Feuillard J., Ferrand C., et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 2009, 145:624-636.
10. Jegalian A.G., Buxbaum N.P., Facchetti F., et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 2010, 95:1873-1879.
11. Tsagarakis N.J., Kentrou N.A., Papadimitriou K.A., et al. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res 2010, 34:438-446.
12. Garnache-Ottou F., Chaperot L., Biichle S., et al. Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Blood 2005, 105:1256-1264.
13. Reimer P., Rüdiger T., Kraemer D., et al. What is CD4+CD56+ malignancy and how should it be treated?. Bone Marrow Transplant 2003, 32:637-646.
14. Dustin M.L., Olszowy M.W., Holdorf A.D., et al. Anovel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 1998, 94:667-677.
15. Marafioti T., Paterson J.C., Ballabio E., et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008, 111:3778-3792.
16. Leroux D., Mugneret F., Callanan M., et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood 2002, 99:4154-4159.
17. Lucioni M., Novara F., Fiandrino G., et al. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood 2011, 118:4591-4594.
18. Dalle S., Beylot-Barry M., Bagot M., et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?. Br J Dermatol 2010, 162:74-79.
19. Pemmaraju N., Thomas D.A., Kantarjian H., et al. Analysis of outcomes of patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN). J Clin Oncol 2012, 30(Suppl.). Abstract 6578.
20. Dietrich S., Andrulis M., Hegenbart U., et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation withmoderately reduced conditioning intensity. Biol Blood Marrow Transplant 2011, 17:1250-1254.
21. Yamaguchi M., Maekawa M., Nakamura Y., Ueda M. Long-term remission of blastic natural killer-cell lymphoma after autologous peripheral blood stem-cell transplantation. Am J Hematol 2005, 80:124-127.
22. Male H.J., Davis M.B., McGuirk J.P., et al. Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission. Int J Hematol 2010, 92:398-400.
23. Chang H.J., Lee M.D., Yi H.G., et al. Acase of blastic plasmacytoid dendritic cell neoplasm initially mimicking cutaneous lupus erythematosus. Cancer Res Treat 2010, 42:239-243.
24. Mitteldorf C., Bertsch H.P., Baumgart M., et al. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q. JEur Acad Dermatol Venereol 2011, 25:1225-1229.
25. Voelkl A., Flaig M., Roehnisch T., et al. Blastic plasmacytoid dendritic cellneoplasm with acute myeloid leukemia successfully treated to a remission currently of 26 months duration. Leuk Res 2011, 35:e61-e63.
26. Fukushi S., Taku F., Aiba S. Blastic plasmacytoid dendritic cell neoplasm on the scalp. Case Rep Dermatol 2011, 3:240-243.
27. Dohm A., Hasenkamp J., Bertsch H.P., et al. Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient. Bone Marrow Transplant 2011, 46:899-900.
28. Ham J.C., Janssen J.J., Boers J.E., et al. Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm. JClin Oncol 2012, 30:e102-e103.
29. Munoz J., Rana J., Inamdar K., et al. Blastic plasmacytoid dendritic cell neoplasm. Am J Hematol 2012, 87:710.
30. Xie W., Zhao Y., Cao L., et al. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature. Med Oncol 2012, 29:2417-2422.
31. Piccin A., Morello E., Svaldi M., et al. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm. Hematol Oncol 2012, 30:210-213.
32. Takiuchi Y., Maruoka H., Aoki K., et al. Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm lacking skin lesion: a borderline case between acute monocytic leukemia. JClin Exp Hematop 2012, 52:107-111.
33. Gambichler T., Pantelaki I., Stücker M. Childhood blastic plasmacytoid dendritic cell neoplasm treated with allogenic stem cell transplantation. Pediatr Dermatol 2013, 30:142-144.
34. Shieh M.P., Reisian N., Walavalkar V., et al. Excessive therapeutic response in a case of blastic plasmacytoid dendritic cell neoplasm. Clin Adv Hematol Oncol 2012, 10:56-59.
35. Suzuki R., Suzumiya J., Nakamura S., et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006, 37:425-431.
36. Pagano L., Valentini C.G., Pulsoni A., et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 2013, 98:239-246.
37. Roos-Weil D., Dietrich S., Boumendil A., et al. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Blood 2013, 121:440-446.
38. Cota C., Vale E., Viana I., et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol 2010, 34:75-87.
39. Trimoreau F., Donnard M., Turlure P., et al. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies. Haematologica 2003, 88. ELT10.
40. Agliano A., Martin-Padura I., Marighetti P., et al. Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm. Clin Cancer Res 2011, 17:6163-6173.
41. Reineks E.Z., Osei E.S., Rosenberg A., et al. CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells. Cytometr B Clin Cytom 2009, 76:237-248.
42. Borchiellini D., Ghibaudo N., Mounier N., et al. Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature. J Eur Acad Dermatol Venereol 2012, 10.1111/j.1468-3083.2012.04503.x.
43. An H.J., Yoon D.H., Kim S., et al. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience. Ann Hematol 2013, 92:351-356.